RET Fusion: Joining the Ranks of Targetable Molecular Drivers in NSCLC by Osta, Badi El, MD, Ramalingam, Suresh S., MD, FACP, FASCO

Get full text

A Phase 1/2 Study to Evaluate the Safety and Activity of Nivolumab in Combination With Vorolanib, a Vascular Endothelial Growth Factor Tyrosine Kinase Inhibitor, in Patients With R... by Beckermann, Kathryn E., MD, PhD, Bestvina, Christine M., MD, El Osta, Badi, MD, Sanborn, Rachel E., MD, Borghaei, Hossein, MD, Lammers, Philip Edward, MD, MSCI, Selvaggi, Giovanni, MD, Whisenant, Jennifer G., PhD, Heimann-Nichols, Ellen, MBA, Berry, Lynne, PhD, Hsu, Chih-Yuan, PhD, Shyr, Yu, PhD, Horn, Leora, MD, MSc, MHPE, Wakelee, Heather, MD, FASCO

Get full text